Mark G. Foletta
Chief Financial Officer, Amylin Pharmaceuticals.
Companies
- ENANTA PHARMACEUTICALS INCBoard member Jul 1, 2020 to now1
- DexcomBoard member Nov 19, 2014 to now2
- AMN HEALTHCARE SERVICES INCBoard member Dec 12, 2012 to now3
- Forte Biosciences, Inc.Chief financial officer Apr 12, 2017 to Oct 4, 20194
- Regulus Therapeutics Inc.Board member Jan 31, 2013 to Dec 6, 20175
- BIOCEPT INCChief financial officer Aug 20, 2015 to Sep 2, 20156
- Ambit BiosciencesBoard member Jan 27, 2014 to Nov 12, 20147
- Amylin PharmaceuticalsChief financial officer Jan 18, 2006 to Feb 24, 20128
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Dexcom DXCM55,183 shares9$4.8M at $86.09Aug 4, 2026
- AMN HEALTHCARE SERVICES INC AMN39,515 shares10$1.6M at $41.35Jun 15, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 3, 2026Sold 2,000 shares at $85.32 of Dexcom9
- Jul 31, 2026Sold 2,000 shares at $80.00 of Dexcom9
- Jun 15, 2026Sold 199 shares at $74.82 of Dexcom11
- Jun 15, 2026Sold 2,000 shares at $31.07 of AMN HEALTHCARE SERVICES INC10
- Jun 15, 2026Sold 3,801 shares at $74.10 of Dexcom11
- Jun 15, 2026Sold 1,681 shares at $31.07 of AMN HEALTHCARE SERVICES INC10
- May 28, 2026Granted 6,331 shares of Dexcom12
- May 8, 2026Gift 5,731 shares of Dexcom13
- May 8, 2026Gift 5,731 shares of Dexcom13
- May 1, 2026Exercised options 8,325 shares of AMN HEALTHCARE SERVICES INC14
- Aug 15, 2025Sold 195 shares at $81.54 of Dexcom15
- Aug 15, 2025Sold 2,555 shares at $81.02 of Dexcom15
- Jul 15, 2025Sold 8 shares at $86.03 of Dexcom16
- Jul 15, 2025Sold 2,742 shares at $85.17 of Dexcom16
- Jun 16, 2025Sold 2,750 shares at $83.13 of Dexcom17
- May 8, 2025Granted 5,731 shares of Dexcom18
- May 8, 2025Gift 2,973 shares of Dexcom18
- May 8, 2025Gift 2,973 shares of Dexcom18
- Apr 19, 2025Exercised options 3,019 shares of AMN HEALTHCARE SERVICES INC19
- Jun 18, 2024Sold 299 shares at $117.25 of Dexcom20
- Jun 18, 2024Sold 3,007 shares at $116.75 of Dexcom20
- Jun 17, 2024Sold 475 shares at $117.77 of Dexcom20
- Jun 17, 2024Sold 2,212 shares at $117.16 of Dexcom20
- Jun 17, 2024Sold 7 shares at $115.18 of Dexcom20
- May 22, 2024Granted 2,973 shares of Dexcom21
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARDexcom, Board member
- 3
- 4
- 5
- 6SEC EDGARBIOCEPT INC, Chief financial officer
- 7SEC EDGARAmbit Biosciences, Board member
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Jun 17, 2026
- 12SEC EDGARForm 4 filed Jun 1, 2026
- 13SEC EDGARForm 4 filed May 11, 2026
- 14SEC EDGARForm 4 filed May 4, 2026
- 15SEC EDGARForm 4 filed Aug 18, 2025
- 16SEC EDGARForm 4 filed Jul 17, 2025
- 17SEC EDGARForm 4 filed Jun 18, 2025
- 18SEC EDGARForm 4 filed May 12, 2025
- 19SEC EDGARForm 4 filed Apr 21, 2025
- 20SEC EDGARForm 4 filed Jun 20, 2024
- 21SEC EDGARForm 4 filed May 24, 2024